From the *Graduate Institute of Nursing, College of Nursing, Taipei Medical University; †Sleep Science Center, Taipei Medical University Hospital; and ‡Department of Anesthesiology, Taipei Tzu Chi Hospital, Taipei; §School of Medicine, Tzu Chi University, Hualien; and ∥School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Reg Anesth Pain Med. 2015 Jan-Feb;40(1):37-42. doi: 10.1097/AAP.0000000000000190.
We examined whether patients with a diagnosis of fibromyalgia have an increased risk of coronary heart disease (CHD), compared with age- and sex-matched control patients. We hypothesized that patients diagnosed with fibromyalgia are at increased risk of adverse coronary events.
Using a matched-cohort study design, we analyzed data retrieved from the Longitudinal Health Insurance Database 2000 released by the National Health Research Institute, Taiwan. The Longitudinal Health Insurance Database 2000 includes medical claims data and registration files for 1 million enrollees randomly selected from the 2000 Registry for Beneficiaries (n = 23.72 million) of the National Health Insurance program. Patients treated for fibromyalgia at least once a month for 3 consecutive months following their initial diagnosis were enrolled in our study. The primary end point was the composite of CHD events, including percutaneous coronary interventions and coronary artery bypass grafting procedures. A propensity score was estimated by a logistic regression method, in which the fibromyalgia status was regressed on baseline prognostic factors. The hazard ratios and the 95% confidence intervals were estimated using multivariate Cox proportional-hazards regression models while adjusting for the propensity score.
After adjusting for the propensity score, the patients with fibromyalgia showed a significantly higher subsequent risk of a CHD event (hazard ratio, 2.11; 95% confidence interval, 1.46-3.05; P < 0.001) than the patients without fibromyalgia.
An association between fibromyalgia and CHD appears to exist.
我们研究了与年龄和性别匹配的对照患者相比,诊断为纤维肌痛的患者是否患有冠心病(CHD)的风险增加。我们假设纤维肌痛患者发生不良冠状动脉事件的风险增加。
使用匹配队列研究设计,我们分析了来自台湾国家健康研究所发布的 2000 年纵向健康保险数据库的数据。2000 年纵向健康保险数据库包括医疗保险索赔数据和登记文件,涵盖了国家健康保险计划 2000 年受益人的随机抽样登记(n = 2372 万)的 100 万参保人。我们的研究纳入了至少在初始诊断后连续 3 个月每月至少接受一次纤维肌痛治疗的患者。主要终点是 CHD 事件的综合指标,包括经皮冠状动脉介入治疗和冠状动脉旁路移植术。使用逻辑回归方法估计倾向评分,其中将纤维肌痛状态回归为基线预后因素。使用多变量 Cox 比例风险回归模型估计风险比和 95%置信区间,同时调整倾向评分。
调整倾向评分后,纤维肌痛患者发生 CHD 事件的风险明显更高(风险比,2.11;95%置信区间,1.46-3.05;P < 0.001)。
纤维肌痛与 CHD 之间似乎存在关联。